No white knight yet as GSK extends deadline on $2.6bn offer for HGS
03:05 EDT 2 Jul 2012 | SCRIP
Without blinking, GlaxoSmithKline has again extended the timeline on its offer to acquire its long-time partner Human Genome Sciences . The offer price remains at $13 per share, but the tender offer has been extended from the previous.....
Original Article: No white knight yet as GSK extends deadline on $2.6bn offer for HGS
More From BioPortfolio on "No white knight yet as GSK extends deadline on $2.6bn offer for HGS"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
